Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They need to hire a full time patent attorney to analyze over 70 patents owned by Lightwave Logic. I wonder if your due diligence includes calling NLM to get their response on this legal hurdle?
Ted,
Why is it that all of those posters who wish to influence the stock price lower only mention the $2.6 million cash bonus earned in 2021? (When the two officers did not exercise any stock options).
It seems to me that anyone claiming to seek the truth would tell the whole truth. In 2022, Lebby and Marcelli were paid cash bonuses representing 67% of target. Lebby: $134,000/$200,000
Marcelli: $93,800/$140,000
Repeat after me with your right hand on the Bible: I, Tedpeele, did not tell the whole story because I was trying to spin the story to benefit myself.”
Around mid April, the next proxy statement will be published. Lebby’s target cash bonus for 2023 was $210,000 and Marcelli’s was $147,000. We will see how the compensation committee values the signing of the first licensing agreement. They are aware of all of the details of that agreement and we are not. We will learn a small amount of information about the agreement in the 10-K at the end of February. But, the proxy statement is really where the whole truth will be revealed.
It was nice to see Lebby’s compensation package increased to market competitive levels in 2022. One could argue he is still underpaid.
The following was a response to me from Luke Zimmerman of the MZ Group dated April 18, 2023. We have always believed the MZ Group was 3rd rate, but cheap enough for Marcelli’s budget.
Luke is saying they meet with small fry institutional investors of managed funds. These are the one on one meetings that take place at Roth events. In my ownership spreadsheet that X publishes in Drop Box quarterly, I changed the category heading to Retail + Boutique Ownership last year. In other words, these small managed funds are viewed by me as retail investors.
Your share tracker is not reflective of the reality "on the ground".
Only funds with $100M+ in assets under management need to file their positions publicly. As a small-cap stock, the vast majority of investors we meet with are sub $100M in assets. Most investors purposefully keep their funds below that point to avoid triggering that requirement. So what you see publicly will never be reflective of the actual institutional holdings.
Thank you for your continued support,
Lucas A Zimmerman
A bit of sarcasm! Best to buy some throat drops to ease the pain of yelling!
Extreme overuse of the WE
I certainly am not part of your universe.
Shhhh. We need to keep our progress quiet just a little longer. Going nuclear is the term.
MNG1, don’t invest more than you can lose. With a stock like this, short sellers could lose way more than they thought was possible.
Watching level two trading, it certainly appears like some short sellers don’t want to play this one anymore. That is a smart move! Just don’t be surprised when everything that Lebby has been saying happens.
All past tense!
Sorry you have been around for 20 years. My first purchase was on May 19, 2021 @ $1.52. I own a lot and will add 50,000 more the minute Lebby signs a Tier One customer or partner.
I am investing for the future and I am basing my decision on what I see happening in the present and the future. I don’t care about the distant past.
MrNewGuy, to keep saying they have achieved nothing in 20 years simply demonstrates that you are not paying attention to what is going on today. If you actually believe nothing is happening today, then you should add to your short position.
Dr Lebby continues to be extremely confident. The way the stock is trading, one would think people at Photonics West picked up on that.
Three years ago there was zero short interest. The actual numbers for year end 2023 will be out in two weeks. I expect very little change from the September ownership numbers.
I agree with your squeeze target and what could cause it.
I guess the rooftop drinks resulted in loose lips!
I am accumulating cash to do just that.
A nasdaq delisting takes about a year to accomplish. First a Nasdaq stock must trade below $1.00/share for six months. Once that occurs, the company receives a letter from the Nasdaq giving them six months to get the stock price above $1.00. If the stock price does exceed $1.00 for ten consecutive trading days, the issue is considered resolved. Then, the whole situation starts all over again.
Folks, this is not going to happen! The odds are perhaps .001%. The odds of a short squeeze occurring in the next two months are probably 50% so let talk about that!!
Don’t be shocked if there is a press release this week.
There have been times when money flows out of the indexes, but it is rare and doesn’t last very long.
The index funds are soaking up more and more of the tradable float. This reduces liquidity and, in the event of significant commercial news, could exacerbate a short squeeze.
Does it matter whether the shares are owned by passive index funds? As long as investors don’t pull money out of the index funds, those shares are not available to short sellers to cover. The decision by the index funds to lend their shares out to short sellers is the important part of the equation. I am only guessing here, but I would think the decision to call in those short shares would not be made by a computer algorithm.
It’s a game of musical chairs!
Blackrock’s position on 9/30/2023 was 7,951,901 shares. This was an increase of just 342 shares from 6/30/2023. Blackrock purchased 639,196 shares in Q4.
I wonder if Blackrock purchased an AI chip from Nvidia which enabled their computer programs to read Lebby’s December 4th shareholder letter.
I recently read that Blackrock experienced an outflow of funds due to OSG activists. I can’t remember the details.
The incredible potential does increase the attractiveness of the buyout scenario. There are many companies that may kick the tires once the technology becomes mainstream.
If a buyout offer was announced suddenly, 100% of the short interest would have to cover and it is possible the stock price could temporarily exceed the buyout price. Since a buyout is a possibility, this risk must be considered by short sellers. The potential gain from selling short is about $4, while the potential loss is something above $30.
I am just pointing out the risk reward ratio. I do not believe a buyout will happen this year. The production lab expansion and new employees are there to support commercial activities. If there is a buyout, the current facilities would be moved into the acquirer’s building.
Everyone reading this board (regardless of their price forecast), must always consider the buyout scenario. The poison pill will create more shares up to 130 million.
$5 billion equals $38. If that was announced abruptly, can you handle that? Your potential is maybe $2 and your potential loss is $???
I have never been more interested in a specific risk/reward scenario. This one is exceptionally interesting.
I believe we have uncovered enough evidence to conclude that the first licensee is neither Polariton or SilOriX. Those are the two that applied Perkinamine to their product and set world records.
So what other company is it? Nobody knows! However, we do know the company has hired about 15 advanced degree new employees to support the business activity generated by the first licensee and others to follow. In addition to these employees, the company has hired a purchasing manager and a controller.
I know we all look forward to learning what is going on, even the shorts want to know.
Only if coated with Perkinamine!
I registered for this conference thinking I would be able to watch the presentation. That is not the case. The entire conference outside of keynote speakers is one-on-one meetings with institutional investors (no index funds). If I remember correctly, these meetings are limited to 20 minutes and are scheduled ahead of time. That’s all I know about it.
Panda was careful not to lie so there is almost no information in his article. For instance,
“Regarding that May 2023 commercial agreement, there were no revenues from it in Q2 and Q3”
He doesn’t acknowledge that revenues did begin in Q4 (October) because that is when the licensee ordered their first batch of Perkinamine. No credible author would leave out 99% of all of the extremely bullish and relevant information.
The only thing he acknowledged was the possibility of a short squeeze. If that does happen, he can claim he was right. (It actually could happen if Lebby’s December 4th prognostication is announced properly).
I have 30 Jan $5 puts that have been or will be assigned today. Net costs are 2000 at $3.21 and 1000 at $3.45. I also have some $7.50 puts with a net cost of $4.45 to $5.22 so not all are below market.
Patent pending is a real thing!
Sorry Ted, I don’t see your posts unless they are in reply to someone else. I am not about to view the VERB board to read your posts there. Actually I was hoping you had shorted it and made a ton of money because I know you really want to load up on Lightwave. You just want a price equal to the cult.
Yes! It does support our suspicions about Ted. I hope he is not a paraplegic even though that would explain a lot.
If he is really a paid short, they picked the right stock to short. One year high was $23.20 and it closed at $.13 Friday. Good job, Ted. I assume you were short.
To be more accurate, Ted’s 5,074th post on VERB was on 9/11/2023 at 6:44 pm.
5,074 posts on VERB
Did anybody make a ton of money shorting VERB? I just got a text message from a friend telling me that Ted actually posts more on that board than he does on this board.
Yes they did and they declined to respond to emails asking if that was the case.
If you follow the MZ Group on LinkedIn, you will see their clients are all startups and they post victorious stories about helping their clients raise a million dollars.
KCCO, I agree with you that these patents are the milestones Lebby referred to in his December 4th letter. I always thought the word milestones was separate from commercial licensing agreements.
Having said that, I think Lebby could have phrased his last sentence differently so as not to be so specific about “before year end”. I think I saw the patent was approved on January 4th and Forztnt informed this board today. Lebby was damn close! I am just very happy that I missed all the incorrect Ted posts YTD about the milestone topic. Guys, you really should use the ignore button!
Agree
I understand the strategy of maintaining secrecy. It seems to be the norm in the high tech world. Because nobody truly knows what is going on under NDAs, the stock has been subject to manipulation. This board is the place where one group is trying very hard to drive the stock lower and another group is trying to prevent them from being successful. The secrecy strategy enhances the naysayer’s effort. If the company could reveal everything, the shorts would have to deal with the truth. However, the secrecy strategy (which seems to be demanded by quite a few companies) permits progress to be made without competition reacting to what they might learn.
In the end, the secrecy will transition into a marketing campaign. Until then, secrecy invites manipulation by modern day traders.